Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting

07/2016 / PloS one

Correlating histologic cellularity with the Apparent Diffusion Coefficient (ADC) measured in MRI (there’s a negative correlation).

Quantification of Tumor Vessels in Glioblastoma Patients Using Time-of-Flight Angiography at 7 Tesla: A Feasibility Study

11/2014 / PloS one

The first in-vivo display of Glioblastoma Tumor vessels with an automatic segmentation algorithm using a 7 Tesla MRI Scanner (it works).

Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent

04/2015 / Radiology

A widely used group of MRI contrast agents is associated with signal intensity elevation in patients’ brains.

Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma

05/2016 / Neuro-Oncology

Clinical parameters in patients with glioblastoma are more relevant for survival prediction than MRI-derived parameters.

Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models

09/2016 / Radiology

Lots of features were extracted from MRI-images (far more than in the study above), a subset of which could better predict survival than clinical parameters.

Radiogenomics of Glioblastoma: Machine Learning–based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features

12/2016 / Radiology

It’s not really possible to predict molecular parameters from MRI-derived parameters.

Time-dependent parameter of perfusion imaging as independent predictor of clinical outcome in symptomatic carotid artery stenosis

04/2016 / BMC Neurology

MRI-derived parameters perform better than sonographically measured degree of stenosis in predicting patient outcomes of symptomatic internal carotid artery stenosis.

Damn, you read this far?

Let me make you an offer you can't refuse: Subscribe to my newsletter and receive precious rants in your inbox every few weeks!